Breast cancer resistance protein (BCRP), another member of the ABC transporter superfamily, has been found to be overexpressed in CRC cells resistant to mitoxantrone, oxaliplatin, cisplatin, doxorubicin, and hydroxycampothecin (16, 39–42). This evidence concerns the gene ABCG2 and colorectal carcinoma.